Home use of mifepristone for medical abortion: a systematic review.

ABSTRACT:

Background

In many countries, persons seeking medical abortion with mifepristone followed by misoprostol can self-administer the second drug, misoprostol, at home, but self-administration of the first drug, mifepristone, is not allowed to the same extent.

Objectives

This systematic review aims to evaluate whether the efficacy, safety and women's satisfaction with abortion treatment are affected when mifepristone is self-administered at home instead of in a clinic.

Search strategy

A literature search covered CINAHL, Cochrane Library, Embase, Ovid MEDLINE and APA PsycInfo in October 2022.

Selection criteria

Eligible studies focused on persons undergoing medical abortion comparing home and in-clinic mifepristone intake. Outcomes included abortion effectiveness, co

SUBMITTER: Gemzell-Danielsson K 

PROVIDER: S-EPMC12322458 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature